<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03918135</url>
  </required_header>
  <id_info>
    <org_study_id>2019TIPF002</org_study_id>
    <nct_id>NCT03918135</nct_id>
  </id_info>
  <brief_title>Comparison of the Efficacy of Intravenous Paracetamol and Ibuprofen in the Treatment of Fever Due to Upper Respiratory Tract Infection</brief_title>
  <official_title>Comparison of the Efficacy of Intravenous Paracetamol and Ibuprofen in Patients With Upper Respiratory Tract Infections Presenting With Fever in the Emergency Department</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pamukkale University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pamukkale University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Currently, paracetamol, ibuprofen and nonsteroidal antiinflammatory drugs are widely used by&#xD;
      emergency physicians in Turkey for the treatment of fever . The objective of the study is&#xD;
      compare the efficacy of intravenous ibuprofen and paracetamol in the treatment of patients&#xD;
      with upper respiratory tract infections presenting with fever in the emergency department&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is the randomized double blinded clinical trial to compare the efficacy of these two&#xD;
      drugs in this clinical setting. A randomized clinical trial was conducted in the Emergency&#xD;
      Department (ED) of Pamukkale University Medical Faculty Hospital Study personnel (emergency&#xD;
      physicians and emergency service nurses) were trained before the study. When intravenous&#xD;
      drugs (Paracetamol and İbuprofen) was being recommended, an eligibility checklist was&#xD;
      completed by the attending physician. patients who presented to the emergency department with&#xD;
      upper respiratory tract infection and had a temperature above 38.0 ° C were measured by a&#xD;
      fever gauge included into the study First Group: 1000 mg of paracetamol ( parol 10mg/ml&#xD;
      solution Mefar, Turkey) intravenous (IV) was given 100 patients&#xD;
&#xD;
      Second Group:&#xD;
&#xD;
      Ibuprofen 400 mg ( intrafen 400mg/4ml solution -Gen ilaç san., Turkey) intravenous (IV) was&#xD;
      given 100 patients which determined to be applied as a group. Drug packs prepared in 150 ml&#xD;
      serum physiology were numbered by an independent nurse, who not involved in the study&#xD;
      Randomization was achieved by using computer software to generate random numbers. During the&#xD;
      intervention, participants were monitored by an oxygen saturation (SpO2) monitor, an&#xD;
      automatic sphygmomanometer (blood pressure), and a rhythm monitor (heart rate and rhythms).&#xD;
      Patients in both groups received two types of medication in a similarmanner, thus ensuring&#xD;
      double blind.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Actual">January 1, 2020</completion_date>
  <primary_completion_date type="Actual">January 1, 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Decreasing of fever</measure>
    <time_frame>Baseline and 120 minutes</time_frame>
    <description>Comparison of the change of fever between the two groups. - (First group Paracetamol, Second Ibuprofen)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">200</enrollment>
  <condition>Fever</condition>
  <arm_group>
    <arm_group_label>Paracetamol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Paracetamol 1000 mg of paracetamol (parol 10mg/ml solution Mefar,Turkey ) intravenous (IV) was given 100 patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>İbuprofen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>İbuprofen 400mg of ibuprofen (intrafen 400mg/4ml solution Gen ilaç sanayi,Turkey ) intravenous (IV) was given 100 patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Paracetamol</intervention_name>
    <description>1000 mg of paracetamol (parol 10mg/ml Mefar, Turkey) intravenous (IV) was given 100 patients&#xD;
Other Names:&#xD;
Perfalgan&#xD;
Paracerol</description>
    <arm_group_label>Paracetamol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ibuprofen</intervention_name>
    <description>400mg of ibuprofen(intrafen 400mg/4ml Gen ilaç sanayi, Turkey) intravenous (IV) was given 100 patients&#xD;
Other Names:&#xD;
Dorifen</description>
    <arm_group_label>İbuprofen</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients who have fever for less than five days&#xD;
&#xD;
          -  At least 1 upper respiratory tract infection (URTI) symptom according URTI questionare&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients use anti-pyretic last 4 hours&#xD;
&#xD;
          -  To be Pregnancy and breast-feeding Patients of childbearing age who are not using a&#xD;
             birth control method&#xD;
&#xD;
          -  Patients with an allergy trait (paracetamol and Ibuprofen) Illiterates&#xD;
&#xD;
          -  Hemodynamically unstable patients&#xD;
&#xD;
          -  Patients with renal transplantation&#xD;
&#xD;
          -  Patients with glucose 6 phosphate dehydrogenase (G6PD) deficiency&#xD;
&#xD;
          -  Patients with non-controlled hypertension&#xD;
&#xD;
          -  Patients with a history of cerebrovascular disease&#xD;
&#xD;
          -  Patients with severe liver, kidney,pulmonary and cardiac heart failure&#xD;
&#xD;
          -  Patients use antibiotics last 7 days&#xD;
&#xD;
          -  Patients with Wolff-Parkinson-White syndrome or accompanying arrhythmias associated&#xD;
             with conductive stimulus delivery in the heart&#xD;
&#xD;
          -  Patients with vision problems&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Atakan Yilmaz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pamukkale University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gizem Oncel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pamukkale University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Pamukkale University</name>
      <address>
        <city>Denizli</city>
        <zip>20070</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>April 15, 2019</study_first_submitted>
  <study_first_submitted_qc>April 15, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 17, 2019</study_first_posted>
  <last_update_submitted>March 8, 2021</last_update_submitted>
  <last_update_submitted_qc>March 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Pamukkale University</investigator_affiliation>
    <investigator_full_name>Üzeyir Çimen</investigator_full_name>
    <investigator_title>Research asistant</investigator_title>
  </responsible_party>
  <keyword>fever, emergency department, paracetamol, ibuprofen, upper respiratory infection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Respiratory Tract Infections</mesh_term>
    <mesh_term>Fever</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Ibuprofen</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

